Photodynamic therapy with fullerenes in vivo: Reality or a dream?

Nanomedicine

Volumn 6, Issue 10, 2011, Pages 1813-1825

  Sharma, Sulbha K ^a   Chiang, Long Y ^b   Hamblin, Michael R ^a,c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b University of Massachusetts Lowell   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

antimicrobial photosensitizers; functionalized fullerenes; hydroxyl radicals; invasive wound infection; mouse models; peritoneal carcinomatosis; photodynamic therapy; singlet oxygen

Indexed keywords

DENDRIMER; FULLERENE DERIVATIVE; FULLEROPYRROLIDINIUM IODIDE; GAMMA CYCLODEXTRIN; LIPOSOME; MACROGOL; MALONIC ACID DERIVATIVE; NANOSPHERE; PHOTOSENSITIZING AGENT; TOBRAMYCIN; UNCLASSIFIED DRUG;

DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENCAPSULATION; GRAM NEGATIVE INFECTION; HUMAN; MICELLE; NANOEMULSION; NONHUMAN; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; REVIEW; STRUCTURE ANALYSIS;

ANIMALS; FULLERENES; HUMANS; HYDROXYL RADICAL; LIGHT; MICE; MODELS, ANIMAL; NANOMEDICINE; NEOPLASMS; PHOTOCHEMISTRY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SINGLET OXYGEN; SUPEROXIDES; WATER;

EID: 82455188574     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.144     Document Type: Review

References (94)

1. Mroz P, Tegos GP, Gali H, Wharton T, Sarna T, Hamblin MR. Photodynamic therapy with fullerenes. Photochem. Photobiol. Sci. 6(11), 1139-1149 (2007). (Pubitemid 350064036)
2. Hamblin MR, Mroz P. Advances In Photodynamic Therapy: Basic, Translational and Clinical. Artech House, Norwood, MA, USA (2008).
3. Agostinis P, Berg K, Cengel KA et al. Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 61(4), 250-281 (2011).
4. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat. Rev. Cancer 3(5), 380-387 (2003). (Pubitemid 37328858)
5. Dougherty TJ, Gomer CJ, Henderson BW et al. Photodynamic therapy. J. Natl Cancer Inst. 90(12), 889-905 (1998). (Pubitemid 28304157)
6. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem. Photobiol. 55(1), 145-157 (1992).
7. Abels C. Targeting of the vascular system of solid tumours by photodynamic therapy (PDT). Photochem. Photobiol. Sci. 3(8), 765-771 (2004). (Pubitemid 39302977)
8. Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 6(7), 535-545 (2006). (Pubitemid 43980542)
9. Hancock RE, Bell A. Antibiotic uptake into Gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 7(6), 713-720 (1988). (Pubitemid 19017153)
10. Detty MR, Gibson SL, Wagner SJ. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J. Med. Chem. 47(16), 3897-3915 (2004). (Pubitemid 38970949)
11. Szeimies RM, Karrer S, Abels C et al. 9-Acetoxy-2,7,12,17-tetrakis-(beta- methoxyethyl)-porphycene (ATMPn), a novel photo sensitizer for photodynamic therapy uptake kinetics and intracellular localization. J. Photochem. Photobiol. B. 34(1), 67-72 (1996). (Pubitemid 26334849)
12. Rosenthal I. Phthalocyanines as photodynamic sensitizers. Photochem. Photobiol. 53(6), 859-870 (1991).
13. Agostinis P, Vantieghem A, Merlevede W, De Witte PA. Hypericin in cancer treatment: more light on the way. Int. J. Biochem. Cell Biol. 34(3), 221-241 (2002). (Pubitemid 34159138)
14. Stockert JC, Juarranz A, Villanueva A, Canete M. Photodynamic damage to HeLa cell microtubules induced by thiazine dyes. Cancer Chemother. Pharmacol. 39(1-2), 167-169 (1996). (Pubitemid 26400677)
15. Bottiroli G, Croce AC, Balzarini P et al. Enzyme-assisted cell photosensitization: a proposal for an effcient approach to tumor therapy and diagnosis. The rose bengal fuorogenic substrate. Photochem. Photobiol 66(3), 374-383 (1997). (Pubitemid 127494528)
16. Cataldo F, Da Ros T. Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes. Springer Science+Business Media, NY, USA (2008).
17. Duncan LK, Jinschek JR, Vikesland PJ. C60 colloid formation in aqueous systems: effects of preparation method on size, structure, and surface charge. Environ. Sci. Technol. 42(1), 173-178 (2008).
18. Hotze EM, Labille J, Alvarez P, Wiesner MR. Mechanisms of photochemistry and reactive oxygen production by fullerene suspensions in water. Environ. Sci. Technol. 42(11), 4175-4180 (2008). (Pubitemid 351770080)
19. Culotta L, Koshland DE Jr. Buckyballs: wide open playing feld for chemists. Science 254(5039), 1706-1709 (1991).
20. Oberdorster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J. Intern. Med. 267(1), 89-105 (2010).
21. Gharbi N, Pressac M, Hadchouel M, Szwarc H, Wilson SR, Moussa F. 60fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity Nano Lett. 5(12), 2578-2585 (2005). (Pubitemid 43088916)
22. Kato S, Aoshima H, Saitoh Y, Miwa N. Biological safety of liposome-fullerene consisting of hydrogenated lecithin, glycine soja sterols, and fullerene-C60 upon photocytotoxicity and bacterial reverse mutagenicity Toxicol. Ind. Health 25(3), 197-203 (2009).
23. Kato S, Aoshima H, Saitoh Y, Miwa N. Fullerene-C60/liposome complex: defensive effects against UVA-induced damages in skin structure, nucleus and collagen type I/IV fbrils, and the permeability into human skin tissue. J. Photochem. Photobiol. B. 98(1), 99-105 (2009).
24. Doi Y, Ikeda A, Akiyama M et al. Intracellular uptake and photodynamic activity of water-soluble 60-and 70fullerenes incorporated in liposomes. Chemistry 14(29), 8892-8897 (2008).
25. Yan A, Von Dem Bussche A, Kane AB, Hurt RH. Tocopheryl polyethylene glycol succinate as a safe, antioxidant surfactant for processing carbon nanotubes and fullerenes. Carbon N Y 45(13), 2463-2470 (2007). (Pubitemid 47588210)
26. Akiyama M, Ikeda A, Shintani T et al. Solubilisation of 60fullerenes using block copolymers and evaluation of their photodynamic activities. Org. Biomol. Chem. 6(6), 1015-1019 (2008).
27. Kojima C, Toi Y, Harada A, Kono K. Aqueous solubilization of fullerenes using poly(amidoamine) dendrimers bearing cyclodextrin and poly(ethylene glycol). Bioconjug Chem. 19(11), 2280-2284 (2008).
28. Pan B, Cui D, Xu P et al. Synthesis and characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes and their application in gene delivery systems. Nanotechnology 20(12), 125101 (2009).
29. Hooper JB, Bedrov D, Smith GD. Supramolecular self-organization in PEO-modifed C60 fullerene/water solutions: infuence of polymer molecular weight and nanoparticle concentration. Langmuir 24(9), 4550-4557 (2008). (Pubitemid 351725132)
30. Nitta N, Seko A, Sonoda A et al. Is the use of fullerene in photodynamic therapy effective for atherosclerosis? Cardiovasc. Intervent. Radiol 31(2), 359-366 (2008). (Pubitemid 351421911)
31. 3+ ions for photodynamic therapy J. Control. Release 117(1), 104-110 (2007). (Pubitemid 46164862)
32. Tabata Y, Murakami Y, Ikada Y Photodynamic effect of polyethylene glycol-modifed fullerene on tumor. Jpn J. Cancer Res. 88(11), 1108-1116 (1997). (Pubitemid 28021483)
33. Filippone S, Heimann F, Rassat A. A highly water-soluble 2:1 beta-cyclodextrin-fullerene conjugate. Chem. Commun. (Camb.) 14, 1508-1509 (2002). (Pubitemid 34743831)
34. Zhao B, He YY, Bilski PJ, Chignell CF. Pristine (C60) and hydroxylated C60(OH)24 fullerene phototoxicity towards HaCaT keratinocytes: type I vs type II mechanisms. Chem. Res. Toxicol. 21(5), 1056-1063 (2008).
35. Bansal T, Mustafa G, Khan ZI, Ahmad FJ, Khar RK, Talegaonkar S. Solid self-nanoemulsifying delivery systems as a platform technology for formulation of poorly soluble drugs. Crit. Rev. Ther. Drug Carrier Syst. 25(1), 63-116 (2008). (Pubitemid 351363757)
36. Shakeel F, Faisal MS. Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib. Pharm. Dev. Technol. 15(1), 53-56 (2009).
37. Bali V, Ali M, Ali J. Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe. J. Drug Target 18(7), 506-519 (2010).
38. Amani A, York P, Chrystyn H, Clark BJ. Factors affecting the stability of nanoemulsions-use of artifcial neural networks. Pharm. Res. 27(1), 37-45 (2010).
39. Boyd PD, Reed CA. Fullerene-porphyrin constructs. Acc. Chem. Res. 38(4), 235-242 (2005).
40. El-Khouly ME, Araki Y, Ito O et al. Spectral, electrochemical, and photophysical studies of a magnesium porphyrin-fullerene dyad. Phys. Chem. Chem. Phys. 7(17), 3163-3171 (2005). (Pubitemid 41363680)
41. Imahori H. Porphyrin-fullerene linked systems as artifcial photosynthetic mimics. Org. Biomol. Chem. 2(10), 1425-1433 (2004).
42. Schuster DI, Cheng P, Jarowski PD et al. Design, synthesis, and photophysical studies of a porphyrin-fullerene dyad with parachute topology; charge recombination in the marcus inverted region. J. Am. Chem. Soc. 126(23), 7257-7270 (2004). (Pubitemid 38747776)
43. Vail SA, Schuster DI, Guldi DM et al. Energy and electron transfer in beta-alkynyl-linked porphyrin-60fullerene dyads. J. Phys. Chem. B. 110(29), 14155-14166 (2006). (Pubitemid 44187974)
44. Gebhart SC, Lin WC, Mahadevan-Jansen A. In vitro determination of normal and neoplastic human brain tissue optical properties using inverse adding-doubling. Phys. Med. Biol. 51(8), 2011-2027 (2006).
45. Tuchin V V, Wang RK, Yeh AT. Optical clearing of tissues and cells. J. Biomed. Opt. 13(2), 021101 (2008).
46. Hirshburg J, Choi B, Nelson JS, Yeh AT. Correlation between collagen solubility and skin optical clearing using sugars. Lasers Surg. Med. 39(2), 140-144 (2007). (Pubitemid 46411407)
47. Jiang J, Boese M, Turner P, Wang RK. Penetration kinetics of dimethyl sulphoxide and glycerol in dynamic optical clearing of porcine skin tissue in vitro studied by Fourier transform infrared spectroscopic imaging. J. Biomed. Opt. 13(2), 021105 (2008).
48. Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci. 123-126, 369-385 (2006). (Pubitemid 44665819)
49. Goeppert-Mayer M. Über elementarakte mit zwei Quantensprüngen. Ann. Phys. 9, 273-295 (1931).
50. Bhawalkar JD, Kumar ND, Zhao CF, Prasad PN. Two-photon photodynamic therapy J. Clin. Laser Med. Surg. 15(5), 201-204 (1997). (Pubitemid 27518371)
51. Karotki A, Khurana M, Lepock JR, Wilson BC. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy Photochem. Photobiol. 82(2), 443-452 (2006).
52. Samkoe KS, Clancy AA, Karotki A, Wilson BC, Cramb DT Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration. J. Biomed. Opt. 12(3), 034025 (2007).
53. Samkoe KS, Cramb DT Application of an ex ovo chicken chorioallantoic membrane model for two-photon excitation photodynamic therapy of age-related macular degeneration. J. Biomed. Opt. 8(3), 410-417 (2003).
54. Arbogast JW, Darmanyan AP, Foote CS et al. Photophysical properties of C60. J. Phys. Chem. A. Mol. Spectrosc. Kinet. Environ. Gen. Theory 95(1), 11-12 (1991).
55. Foote CS. Photophysical and photochemical properties of fullerenes Top. Curr. Chem. 169, 347-363 (1994).
56. 2. J. Am. Chem. Soc. 125(42), 12803-12809 (2003). (Pubitemid 37280449)
57. Koeppe R, Sariciftci NS. Photoinduced charge and energy transfer involving fullerene derivatives. Photochem. Photobiol. Sci. 5(12), 1122-1131 (2006). (Pubitemid 44853765)
58. Guldi DM, Prato M. Excited-state properties of C(60) fullerene derivatives. Acc. Chem. Res. 33(10), 695-703 (2000).
59. Arbogast JW, Foote CS, Kao M. Electron-transfer to triplet C-60. J. Am. Chem. Soc. 114(6), 2277-2279 (1992).
60. Lens M, Medenica L, Citernesi U. Antioxidative capacity of C(60) (buckminsterfullerene) and newly synthesized fulleropyrrolidine derivatives encapsulated in liposomes. Biotechnol. Appl. Biochem. 51(Pt 3), 135-140 (2008).
61. Spohn P, Hirsch C, Hasler F, Bruinink A, Krug HF, Wick P. C60 fullerene: a powerful antioxidant or a damaging agent? The importance of an in-depth material characterization prior to toxicity assays. Environ. Pollut. 157(4), 1134-1139 (2009).
62. +-induced cellular model of Parkinson's disease. J. Neurosci. Res. 86(16), 3622-3634 (2008).
63. Dugan LL, Gabrielsen JK, Yu SP, Lin TS, Choi DW Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol. Neurosci. 3(2), 129-135 (1996). (Pubitemid 26275342)
64. Andrievsky GV, Bruskov VI, Tykhomyrov AA, Gudkov SV. Peculiarities of the antioxidant and radioprotective effects of hydrated C60 fullerene nanostuctures in vitro and in vivo. Free Radic. Biol. Med. 47(6), 786-793 (2009).
65. Weiss DR, Raschke TM, Levitt M. How hydrophobic buckminsterfullerene affects surrounding water structure. J. Phys. Chem. B. 112(10), 2981-2990 (2008).
66. Tokuyama H, Yamago S, Nakamura E. Photoinduced biochemical activity of fullerene carboxylic acid. J. Am. Chem. Soc. 115, 7918-7919 (1993). (Pubitemid 23300651)
67. Burlaka AP, Sidorik YP, Prylutska SV et al. Catalytic system of the reactive oxygen species on the C60 fullerene basis. Exp. Oncol. 26(4), 326-327 (2004).
68. Rancan F, Rosan S, Boehm F et al. Cytotoxicity and photocytotoxicity of a dendritic C(60) mono-adduct and a malonic acid C(60) tris-adduct on Jurkat cells. J. Photochem. Photobiol. B. 67(3), 157-162 (2002). (Pubitemid 34965855)
69. Yang XL, Fan CH, Zhu HS. Photo-induced cytotoxicity of malonic acid C(60)fullerene derivatives and its mechanism. Toxicol. In Vitro 16(1), 41-46 (2002). (Pubitemid 34112635)
70. Mroz P, Pawlak A, Satti M et al. Functionalized fullerenes mediate photodynamic killing of cancer cells: type I versus type II photochemical mechanism. Free Radic. Biol. Med. 43(5), 711-719 (2007). (Pubitemid 47102125)
71. Chiang LY, Padmawar PA, Rogers-Haley JE et al. Synthesis and characterization of highly photoresponsive fullerenyl dyads with a close chromophore antenna-C(60) contact and effective photodynamic potential. J. Mater. Chem. 20(25), 5280-5293 (2010).
72. Kasermann F, Kempf C. Photodynamic inactivation of enveloped viruses by buckminsterfullerene. Antiviral Res. 34(1), 65-70 (1997). (Pubitemid 27132858)
73. Hirayama J, Abe H, Kamo N et al. Photoinactivation of vesicular stomatitis virus with fullerene conjugated with methoxy polyethylene glycol amine. Biol. Pharm. Bull. 22(10), 1106-1109 (1999). (Pubitemid 29507952)
74. Lin CP, Lynch MC, Kochevar IE. Reactive oxidizing species produced near the plasma membrane induce apoptosis in bovine aorta endothelial cells. Exp. Cell Res. 259(2), 351-359 (2000).
75. Lee I, Mackeyev Y, Cho M et al. Photochemical and antimicrobial properties of novel C60 derivatives in aqueous systems. Environ. Sci. Technol. 43(17), 6604-6610 (2009).
76. Tegos GP, Demidova TN, Arcila-Lopez D et al. Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem. Biol. 12(10), 1127-1135 (2005). (Pubitemid 41483630)
77. Spesia MB, Milanesio ME, Durantini EN. Synthesis, properties and photodynamic inactivation of Escherichia coli by novel cationic fullerene C60 derivatives. Eur. J. Med. Chem. 43(4), 853-861 (2008). (Pubitemid 351446156)
78. Huang L, Terakawa M, Zhiyentayev T et al. Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials. Nanomedicine 6(3), 442-452 (2009).
79. Mizuno K, Zhiyentayev T, Huang L et al. Antimicrobial photodynamic therapy with functionalized fullerenes: quantitative structure-activity relationships. J. Nanomedic. Nanotechnol. 2(2), 100109-100117 (2011).
80. Isobe H, Tomita N, Nakamura E. One-step multiple addition of amine to 60fullerene. synthesis of tetra(amino)fullerene epoxide under photochemical aerobic conditions. Org. Lett. 2(23), 3663-3665. (2000).
81. Ikeda A, Doi Y, Nishiguchi K et al. Induction of cell death by photodynamic therapy with water-soluble lipid-membrane-incorporated 60fullerene. Org. Biomol. Chem. 5(8), 1158-1160 (2007). (Pubitemid 46543570)
82. Ikeda A, Matsumoto M, Akiyama M, Kikuchi J, Ogawa T, Takeya T. Direct and short-time uptake of 70fullerene into the cell membrane using an exchange reaction from a 70fullerene-gamma-cyclodextrin complex and the resulting photodynamic activity. Chem. Commun. (Camb.) 12, 1547-1549 (2009).
83. Ikeda A, Nagano M, Akiyama M et al. Photodynamic activity of C70 caged within surface-cross-linked liposomes. Chem. Asian J. 4(1), 199-205 (2009).
84. Scrivens JMT, K.E. Creek, L Pirisi. Synthesis of C-14-labeled C-60, its suspension in water, and its uptake by human keratinocytes. J. Am. Chem. Soc. 116, 4517-4518. (1994). (Pubitemid 24978437)
85. Foley S, Crowley C, Smaihi M et al. Cellular localisation of a water-soluble fullerene derivative. Biochem. Biophys. Res. Commun. 294(1), 116-119 (2002). (Pubitemid 34687223)
86. Porter AE, Gass M, Muller K, Skepper JN, Midgley P, Welland M. Visualizing the uptake of C60 to the cytoplasm and nucleus of human monocyte-derived macrophage cells using energy-fltered transmission electron microscopy and electron tomography. Environ. Sci. Technol. 41(8), 3012-3017 (2007). (Pubitemid 46626435)
87. Levi N, Hantgan RR, Lively MO, Carroll DL, Prasad GL. C60-Fullerenes: detection of intracellular photoluminescence and lack of cytotoxic effects. J. Nanobiotechnol. 4, 14-25 (2006).
88. Tabata Y, Murakami Y, Ikada Y. Photodynamic effect of polyethylene glycol-modifed fullerene on tumor. Jpn J. Cancer Res. 88(11), 1108-1116 (1997). (Pubitemid 28021483)
89. Chi Y, Canteenwala T, Chen HC, Chen BJ, Canteenwala M, Chiang LY. Hexa(sulfobutyl) fullerene-induced photodynamic effect on tumors in vivo and toxicity study in rats. Proc. Electrochem. Soc. 99, 234-249 (1999).
90. Otake E, Sakuma S, Torii K et al. Effect and mechanism of a new photodynamic therapy with glycoconjugated fullerene. Photochem. Photobiol. 86(6), 1356-1363 (2010).
91. Mroz P, Xia Y, Asanuma D et al. Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma. Nanomedicine doi:10.1016/j.
92. nano.2011.04.007 (2011) (Epub ahead of print).
93. Lu Z, Dai T, Huang L et al. Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond.) 5(10), 1525-1533 (2010).
94. Chen HH, Yu C, Ueng TH et al. Acute and subacute toxicity study of water-soluble polyalkylsulfonated C60 in rats. Toxicol. Pathol. 26(1), 143-151 (1998). (Pubitemid 28100699)